Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 3.72 MB
Add to list
  1. Search results
  2. Moderate hypofractionated radiotherap...

Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

Valerie Fonteyne (UGent) , C Berghen, Charles Van Praet (UGent) , Barbara Vanderstraeten (UGent) , Sofie Verbeke (UGent) , Geert Villeirs (UGent) , Roos Colman (UGent) , Ben Vanneste (UGent) , Piet Ost (UGent) , G De Meerleer, et al.
(2024) RADIOTHERAPY AND ONCOLOGY. 193.
Author
Organization
Keywords
Moderate hypofractionated radiotherapy, Prostate cancer, Toxicity

Downloads

  • Download
    (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 3.72 MB

Citation

Please use this url to cite or link to this publication:

MLA
Fonteyne, Valerie, et al. “Moderate Hypofractionated Radiotherapy for Prostate Cancer : 3-Year Toxicity Results of a Multicentre Randomized Phase 3, Non-Inferiority Trial.” RADIOTHERAPY AND ONCOLOGY, vol. 193, 2024, doi:10.1016/j.radonc.2024.110089.
APA
Fonteyne, V., Berghen, C., Van Praet, C., Vanderstraeten, B., Verbeke, S., Villeirs, G., … Lumen, N. (2024). Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial. RADIOTHERAPY AND ONCOLOGY, 193. https://doi.org/10.1016/j.radonc.2024.110089
Chicago author-date
Fonteyne, Valerie, C Berghen, Charles Van Praet, Barbara Vanderstraeten, Sofie Verbeke, Geert Villeirs, Roos Colman, et al. 2024. “Moderate Hypofractionated Radiotherapy for Prostate Cancer : 3-Year Toxicity Results of a Multicentre Randomized Phase 3, Non-Inferiority Trial.” RADIOTHERAPY AND ONCOLOGY 193. https://doi.org/10.1016/j.radonc.2024.110089.
Chicago author-date (all authors)
Fonteyne, Valerie, C Berghen, Charles Van Praet, Barbara Vanderstraeten, Sofie Verbeke, Geert Villeirs, Roos Colman, Ben Vanneste, Piet Ost, G De Meerleer, and Nicolaas Lumen. 2024. “Moderate Hypofractionated Radiotherapy for Prostate Cancer : 3-Year Toxicity Results of a Multicentre Randomized Phase 3, Non-Inferiority Trial.” RADIOTHERAPY AND ONCOLOGY 193. doi:10.1016/j.radonc.2024.110089.
Vancouver
1.
Fonteyne V, Berghen C, Van Praet C, Vanderstraeten B, Verbeke S, Villeirs G, et al. Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial. RADIOTHERAPY AND ONCOLOGY. 2024;193.
IEEE
[1]
V. Fonteyne et al., “Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial,” RADIOTHERAPY AND ONCOLOGY, vol. 193, 2024.
@article{01HR6V4FRVAFA520YNWYFBSBN3,
  articleno    = {{110089}},
  author       = {{Fonteyne, Valerie and  Berghen, C and Van Praet, Charles and Vanderstraeten, Barbara and Verbeke, Sofie and Villeirs, Geert and Colman, Roos and Vanneste, Ben and Ost, Piet and  De Meerleer, G and Lumen, Nicolaas}},
  issn         = {{0167-8140}},
  journal      = {{RADIOTHERAPY AND ONCOLOGY}},
  keywords     = {{Moderate hypofractionated radiotherapy,Prostate cancer,Toxicity}},
  language     = {{eng}},
  pages        = {{6}},
  title        = {{Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial}},
  url          = {{http://doi.org/10.1016/j.radonc.2024.110089}},
  volume       = {{193}},
  year         = {{2024}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: